文献速递免疫规划传染病防控与疫情报告

菲律宾5-7岁儿童乙肝表面抗原血清阳性率调查

Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
PubMed 文献 · Vaccine · 2021-03-09

菲律宾2018年采用三阶段整群抽样开展家庭血清学调查,用快速即时检测方法检测2178名5-7岁儿童乙肝表面抗原(HBsAg),阳性率为0.8%(95%CI 0.4-1.7)。乙肝疫苗出生剂次覆盖率53%、三剂覆盖率73%,医疗机构外出生儿童及时接种出生剂次的调整比值比为0.10(95%CI 0.04-0.23)。

要点

  • 菲律宾5-7岁儿童HBsAg阳性率为0.8%,较疫苗前成人16.7%明显下降。
  • 乙肝疫苗出生剂次覆盖率53%,三剂覆盖率73%,均低于西太区≥95%目标。
  • 医疗机构外出生儿童及时接种出生剂次的可能性显著更低(aOR 0.10)。

核心结论

  • 菲律宾5-7岁儿童HBsAg阳性率已降至0.8%,较疫苗前成人16.7%明显下降。
  • 需确保所有儿童无论出生地点均及时接种乙肝疫苗出生剂次,并提高出生剂次和三剂覆盖率以达西太区≥95%目标。

研究设计与样本

  • 2018年在菲律宾开展家庭血清学调查,采用三阶段整群抽样(省、群、户)。
  • 共检测2178名5-7岁儿童,用快速即时检测方法测HBsAg,通过接种记录或照护者回忆计算疫苗覆盖率,问卷收集人口学变量,分析考虑复杂抽样设计。

主要发现

  • 2178名受检儿童中15名HBsAg阳性,阳性率0.8%(95%CI 0.4-1.7)。
  • 15名HBsAg阳性儿童中仅2名完成全程乙肝疫苗接种。
  • 乙肝疫苗出生剂次覆盖率53%,第三剂覆盖率73%。
  • 在1362名有出生剂次记录儿童中,及时出生剂次接种率(出生24小时内)为43%。
  • 医疗机构外出生儿童较医疗机构内出生儿童及时接种出生剂次的调整比值比为0.10(95%CI 0.04-0.23)。

关键数值与推荐

  • 世界卫生组织西太区目标:2017年5岁儿童HBsAg流行率<1%。
  • 西太区乙肝疫苗覆盖率目标:≥95%。
  • 乙肝疫苗出生剂次覆盖率53%,第三剂覆盖率73%,及时出生剂次接种率43%。

临床怎么用

  • 监测儿童HBsAg阳性率以评估乙肝疫苗接种规划效果。
  • 重点提高医疗机构外出生儿童的及时乙肝疫苗出生剂次接种率。
  • 提升乙肝疫苗出生剂次和三剂覆盖率以接近西太区≥95%目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The World Health Organization Western Pacific Region (WPR) set a hepatitis B virus (HBV) control target to achieve HBV surface antigen (HBsAg) prevalence of <1% among children aged 5 years by 2017. The estimated HBsAg prevalence in the Philippines among adults was 16.7% during the pre-vaccine era. We estimated the HBsAg seroprevalence among children aged 5-7 years to measure the impact of vaccination. We conducted a household serosurvey, using a three-stage cluster survey methodology (provinces, clusters, and households). We estimated HBsAg prevalence using a rapid, point-of-care HBsAg test and calculated vaccination coverage by reviewing vaccination records or by caregiver recall. A questionnaire was administered to assess demographic variables for the child and family. We assessed the association between chronic HBV infection, vaccination coverage, and demographic variables, accounting for the complex survey design. Of the 2178 children tested, HBsAg was detected in 15 children [0.8%, 95% confidence interval (CI): 0.4, 1.7]. Only two of the HBsAg-positive children had been fully vaccinated against HBV. Based on documented vaccination or caregiver recall for the survey population, hepatitis B vaccine birth dose (HepB-BD) coverage was 53%, and the third dose hepatitis B vaccination (HepB3) coverage was 73 percent. Among the 1362 children with documented HepB-BD, timely HepB-BD coverage (given within 24 h of birth) was 43%; children born outside a health facility were less likely to receive a timely HepB-BD than those born in a health facility (adjusted odds ratio 0.10, 95% CI: 0.04, 0.23). HBsAg prevalence among children in the Philippines has decreased compared to the prevalence among adults in the pre-vaccination era. Strategies to further reduce HBsAg prevalence include ensuring that all children, whether born in health facilities or at home, receive a timely HepB-BD, and increasing HepB-BD and HepB3 coverage to reach the WPR goals of ≥95% coverage.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Minta AA, Silva MWT, Shrestha A, et al. Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018. Vaccine. 2021. PMID: 33712351. doi:10.1016/j.vaccine.2021.02.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。